R-Biopharm AG-医療機器分野:企業M&A・提携分析

◆英語タイトル:R-Biopharm AG - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011064
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
R-Biopharm AG (R-Biopharm), a subsidiary of Rohm GmbH is a clinical diagnostics center that test solutions for clinical diagnostics and food and feed analysis. The center offers test systems in the areas of infectological stool diagnostics, serological infection and allergy diagnostics for clinical diagnostics. It also provides food analysis test kits for the analysis of mycotoxins, antibiotics, hormones, genetically modified organisms, risk material, food allergens and microorganisms. R-Biopharm’s clinical products include allergy diagnostics, antibody detection, antigen detection, delayed food allergy, diagnostics, gastroenterology, histamine release, detection, molecular diagnostics and vitamin diagnostics. The center serves biotechnology and pharmaceutical industries. It has its presence in the UK, USA, Italy, France, Latin America, Brazil, Spain, Australia and China. R-Biopharm is headquartered in Darmstadt, Germany.

R-Biopharm AG – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
R-Biopharm AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
R-Biopharm AG, Medical Equipment Deals By Type, 2011 to YTD 2017 6
R-Biopharm AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
R-Biopharm AG, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
R-Biopharm AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
R-Biopharm AG, Medical Equipment, Deal Details 10
Partnerships 10
Gold Standard Diagnostics Enters into Distribution Agreement with R-Biopharm 10
R-Biopharm Enters into Agreement with HMNC Brain Health 11
R-Biopharm Enters into Agreement with Merck 12
Apogenix Enters into Agreement with R-Biopharm 13
PROGEN Biotechnik Enters Into Distribution Agreement With Mitsubishi Chemical 14
Acquisition 15
R-Biopharm Acquires Majority Stake In Humatrix 15
R-Biopharm AG – Key Competitors 16
R-Biopharm AG – Key Employees 17
R-Biopharm AG – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 20
Product News 20
Jul 21, 2016: RIDA SMART APP: New update for mycotoxin app 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
R-Biopharm AG, Medical Equipment, Key Facts 2
R-Biopharm AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
R-Biopharm AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
R-Biopharm AG, Medical Equipment Deals By Type, 2011 to YTD 2017 6
R-Biopharm AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
R-Biopharm AG, Deals By Market, 2011 to YTD 2017 8
R-Biopharm AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Gold Standard Diagnostics Enters into Distribution Agreement with R-Biopharm 10
R-Biopharm Enters into Agreement with HMNC Brain Health 11
R-Biopharm Enters into Agreement with Merck 12
Apogenix Enters into Agreement with R-Biopharm 13
PROGEN Biotechnik Enters Into Distribution Agreement With Mitsubishi Chemical 14
R-Biopharm Acquires Majority Stake In Humatrix 15
R-Biopharm AG, Key Competitors 16
R-Biopharm AG, Key Employees 17
R-Biopharm AG, Subsidiaries 18

★海外企業調査レポート[R-Biopharm AG-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Arcadia Biosciences Inc (RKDA):企業の財務・戦略的SWOT分析
    Summary Arcadia Biosciences Inc (Arcadia) is an agricultural and clean technology company that develops and commercializes agricultural products. Its major products include goodwheat branded ingredients, nutritional oils, animal nutrition and agricultural products. The company's products exhibit tra …
  • Swietelsky Baugesellschaft mbH:企業の戦略的SWOT分析
    Swietelsky Baugesellschaft mbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Kareo Inc:医療機器:M&Aディール及び事業提携情報
    Summary Kareo Inc (Kareo) provides a cloud-based medical technology platform that meets the needs of healthcare providers. The company offers cloud-based electronic health records (EHR) that helps clinicians to manage the care of the patients and record or access required information at the point of …
  • MITIE Group Plc (MTO):企業の財務・戦略的SWOT分析
    MITIE Group Plc (MTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Alps Industries Ltd.:企業の戦略・SWOT・財務分析
    Alps Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Alps Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Austin Industries, Inc.:企業の戦略・SWOT・財務情報
    Austin Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Austin Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • China Chemical & Pharmaceutical Co Ltd (1701):企業の財務・戦略的SWOT分析
    China Chemical & Pharmaceutical Co Ltd (1701) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Midatech Pharma US Inc-製薬・医療分野:企業M&A・提携分析
    Summary Midatech Pharma US Inc (Midatech Pharma), formerly DARA BioSciences, Inc., is a pharmaceutical company which focuses on the development and commercialization of cancer treatment and supportive care products. The company’s product portfolio includes Soltamox for the treatment and prevention o …
  • Birchcliff Energy Ltd (BIR):石油・ガス:M&Aディール及び事業提携情報
    Summary Birchcliff Energy Ltd. (Birchcliff) is an intermediate oil and gas company that explores for, develops and produces natural gas, light oil and natural gas liquids. Its product portfolio includes crude oil, natural gas, natural gas liquids, and light and medium oils. The company operates in t …
  • Owens & Minor Inc (OMI)-製薬・医療分野:企業M&A・提携分析
    Summary Owens & Minor Inc (Owens & Minor) is a healthcare services company, which provides supply chain services to healthcare providers and manufacturers of healthcare products. It provides logistics services for disposable medical supplies, devices and implants. Owens & Minor offers medical and su …
  • Kleo Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Kleo Pharmaceuticals Inc (Kleo Pharmaceuticals) is a biotechnology company that develops small molecules in the field of immunotherapy to emulate biologics. The company provides adaptable technology platforms such as antibody recruiting molecules (ARMs) and synthetic antibody mimics (SyAMs) …
  • Hill-Rom Holdings Inc (HRC):企業の財務・戦略的SWOT分析
    Hill-Rom Holdings Inc (HRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Vectura Group Plc (VEC):製薬・医療:M&Aディール及び事業提携情報
    Summary Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform. It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD) …
  • Astrazeneca Pharma India Ltd (ASTRAZEN):企業の財務・戦略的SWOT分析
    Summary AstraZeneca Pharma India Ltd (AstraZeneca), is a biopharmaceutical company that discovers, develops, and commercializes medicines. The company offers products in the therapeutic areas including cardiovascular and metabolic diseases, respiratory, maternal healthcare, oncology, infection, neur …
  • Alligator Bioscience AB (ATORX):製薬・医療:M&Aディール及び事業提携情報
    Summary Alligator Bioscience AB (Alligator Bioscience) is a clinical-stage biotechnology company that discovers and develops antibody based pharmaceuticals for the treatment of cancer. The company’s pipeline products include ADC-1013, ATOR-1015, ATOR-1017 and ALG.APV-527. The ADC-1013, currently und …
  • Immunomedics Inc (IMMU):企業の財務・戦略的SWOT分析
    Immunomedics Inc (IMMU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Aridis Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Aridis Pharmaceuticals Inc (Aridis) is a biopharmaceutical companythat focusses on development of novel, differentiated therapies for infectious diseases. The company’s pipeline product uses disruptive platform technology to discover potent human monoclonal antibodies from patients.Its propr …
  • Cytogel Pharma LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Cytogel Pharma LLC (Cytogel Pharma) is a biopharmaceutical development company that provides platform technologies and product candidates. The company offers novel analgesic product candidates and polymer and hydrogel drug delivery platform technologies. Its analgesic product candidates offe …
  • Alliance Data Systems Corp (ADS):企業の財務・戦略的SWOT分析
    Alliance Data Systems Corp (ADS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Global Insurance Management Limited:企業の戦略・SWOT・財務分析
    Global Insurance Management Limited - Strategy, SWOT and Corporate Finance Report Summary Global Insurance Management Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆